EDGAR Filing Documents for 0001193125-08-153889

Form 8-K - Current report:

SEC Accession No. 0001193125-08-153889

Filing Date

2008-07-21

Accepted

2008-07-21 08:00:44

Documents

Period of Report

2008-07-18

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	16045
2	FORM OF PURCHASER WARRANT	dex41.htm	EX-4.1	73545
3	FORM OF PLACEMENT AGENT WARRANT	dex42.htm	EX-4.2	71367
4	FORM OF SECURITIES PURCHASE AGREEMENT	dex101.htm	EX-10.1	133699
5	PLACEMENT AGENT AGREEMENT	dex102.htm	EX-10.2	67575
6	ESCROW DEPOSIT AGREEMENT	dex103.htm	EX-10.3	40931
7	PRESS RELEASE	dex991.htm	EX-99.1	9912
8	GRAPHIC	g35404ex991_p1.jpg	GRAPHIC	15371
	Complete submission text file	0001193125-08-153889.txt		436258

Mailing Address 3611 VALLEY CENTRE DRIVE, SUITE 525 SAN DIEGO CA 92130

Business Address 3611 VALLEY CENTRE DRIVE, SUITE 525 SAN DIEGO CA 92130 (858) 436-1000

Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33635 | Film No.: 08960335
SIC: 2836 Biological Products, (No Diagnostic Substances)